Merck Bolsters Oncology Pipeline with $2.13 Billion SciBrunch Licensing Deal for KRAS G12D Inhibitor
In a significant move to reshape its oncology portfolio ahead of impending patent cliffs, Merck & Co. has secured exclusive...
licensing
AstraZeneca Bolsters Oncology Franchise with $1.5 Billion Global Licensing Deal for Dizal’s Zegfrovy
In a major strategic maneuver that underscores the shifting landscape of global pharmaceutical partnerships, AstraZeneca has announced a definitive agreement...
Navigating the Future of Collaboration: Inside the ONLYOFFICE DocSpace 3.7 Release and Licensing Evolution
The landscape of enterprise collaboration software is currently undergoing a period of intense scrutiny and rapid innovation. As organizations shift...
